Table 2.
Impact of COVID-19 of preexisting headache
| Variables | Patient with Migraine | p | Patients with TTH | p | ||
|---|---|---|---|---|---|---|
| Before infection | After infection | Before infection | After infection | |||
| Attack severity | ||||||
| Mean ± SD | 7.235 ± 2.05 | 7.42 ± 2.36 | 0.501 | 5.556 ± 1.86 | 7 ± 2.25 | 0.033* |
| Headache days per month | ||||||
| Means± SD | 8.18 ± 7.36 | 8.55 ± 7.17 | 0.584 | 7 ± 6.29 | 12.72 ± 7.96 | 0.006* |
| Analgesic use days per month | ||||||
| Means± SD | 2.31 ± 1.65 | 3.05 ± 2.09 | 0.002* | 2.28 ± 1.74 | 3.06 ± 2.44 | 0.177 |
COVID-19 Coronavirus disease-19, SD standard deviation, TTH tension type headache
*=P < 0.05, Paired sample t-test